Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitekalostpx.com
CategoryBioTech
Phone858-552-6890
Employees
Founded2005

Offices

San Diego, USA
4370 La Jolla Village
Ste 400
San Diego, CA, 92122
USA

People

President and CMO of Kalos Therapeutics
Executive Chairman and Co-Founder

Funding

DEBT TOTAL $20k
Debt, 2/2013
$20k

Tags

Kalos Therapeutics

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer. Kalos is aggressively targeting diseases caused by an abnormally high growth rate of cells (hyperproliferation). Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
Edit This Page
Last Edited 6/21/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy